Global Pharmaceuticals & Biotech Strong Balance Sheet Stocks

Arbutus Biopharma

Market Cap: US$828.1m

A clinical-stage biopharmaceutical company, develops novel therapeutics for infectious disease in the United States.

Kalaris Therapeutics

Market Cap: US$89.2m

A clinical-stage ophthalmology biotech company, engages in developing therapies for the treatment of neovascular retinal diseases.

Prothena

Market Cap: US$503.8m

A late-stage clinical biotechnology company, focuses on discovery and development of novel therapies to treat diseases caused by protein dysregulation in the United States.

Immix Biopharma

Market Cap: US$66.6m

A clinical-stage biopharmaceutical company, engages in the development of chimeric antigen receptor cell therapy in light chain Amyloidosis and immune-mediated diseases in the United States and Australia.

genXone

Market Cap: zł19.1m

Operates in the biotechnology industry in Poland and internationally.

OpGen

Market Cap: US$1.0k

A precision medicine company, develops and commercializes molecular microbiology solutions for life threatening infectious diseases in the United States and internationally.

Generation Bio

Market Cap: US$38.5m

A biotechnology company, discovers, develops, and commercializes redosable therapeutics that reprogram T cells in vivo to reduce or eliminate the production and persistence of autoreactive T cells.

Isofol Medical

Market Cap: SEK 227.7m

Operates as a clinical stage biotech company.

Avidity Biosciences

Market Cap: US$5.9b

A biopharmaceutical company, engages in the delivery of RNA therapeutics called antibody oligonucleotide conjugates (AOCs).

Genenta Science

Market Cap: US$57.2m

A clinical-stage biotechnology company, engages in the development of hematopoietic stem cell gene therapies for the treatment of solid tumors in Italy.

SNDL

Market Cap: US$633.1m

Engages in the production, distribution, and sale of cannabis products for the adult-use market in Canada.

ORIC Pharmaceuticals

Market Cap: US$1.0b

A clinical-stage biopharmaceutical company, engages in the discovery and development of therapies to counter the resistance mechanisms cancers in the United States.

Alexandria For Pharmaceuticals & Chemical Industries

Market Cap: ج.م3.4b

Manufactures, markets, and distributes generic forms of human and animal health products in Egypt.

Can-Fite BioPharma

Market Cap: ₪47.3m

A clinical-stage biopharmaceutical company, develops orally bioavailable small molecule therapeutic products for the treatment of cancer, liver inflammatory diseases, and erectile dysfunction in Israel.

Dextech Medical

Market Cap: €162.7m

Engages in the development of drug candidates with application in urological oncology, primarily prostate cancer.

AbCellera Biologics

Market Cap: US$1.4b

Engages in discovering and developing antibody-based medicines for indications with unmet medical need in the United States.

Tonix Pharmaceuticals Holding

Market Cap: US$210.4m

A biopharmaceutical company, focuses on developing and commercializing therapeutics to treat and prevent human disease.

Moderna

Market Cap: US$9.6b

A biotechnology company, provides messenger RNA medicines in the United States, Europe, and internationally.

Contineum Therapeutics

Market Cap: US$304.5m

A clinical stage biopharmaceutical company, engages in developing of small molecules different therapies for neuroscience, inflammation, and immunology indications with high unmet need in the United States.

Agios Pharmaceuticals

Market Cap: US$2.1b

A biopharmaceutical company, discovers and develops medicines in the field of cellular metabolism in the United States.

Natera

Market Cap: US$22.5b

A diagnostics company, provides molecular testing services worldwide.

NLS Pharmaceutics

Market Cap: US$6.5m

A clinical-stage biopharmaceutical company, engages in the discovery and development of therapies for patients with rare and complex central nervous system disorders.

Joinn Laboratories(China)Co.Ltd

Market Cap: CN¥25.4b

Provides preclinical and non-clinical services in the United States, the People’s Republic of China, and internationally.

Kotra Industries Berhad

Market Cap: RM 627.4m

An investment holding company, develops, manufactures, and trades in pharmaceutical and healthcare products in Malaysia.

Cuorips

Market Cap: JP¥59.6b

Engages in the research, development, manufacture, commercialization, and sale of iPS cell-derived cardiomyocyte sheets.

United Laboratories International Holdings

Market Cap: HK$29.2b

An investment holding company, engages in the research and development, manufacture, distribution, and sale of pharmaceutical products.

Chongqing Pharscin Pharmaceutical

Market Cap: CN¥6.8b

Chongqing Pharscin Pharmaceutical Co., Ltd.

Taho Pharmaceuticals

Market Cap: NT$9.6b

A pharmaceutical company, develops products using transdermal and transmucosal systems in Taiwan.

Hangzhou Tigermed Consulting

Market Cap: CN¥48.4b

Provides contract research organization services in the People’s Republic of China and internationally.

Energenesis BiomedicalLTD

Market Cap: NT$4.7b

Operates in the biomedicine industry in Taiwan.

Amplia Therapeutics

Market Cap: AU$77.0m

A clinical-stage drug development company, engages in the development of focal adhesion kinase (FAK) inhibitors for cancer and fibrosis in Australia.

Jerusalem Pharmaceuticals

Market Cap: US$72.0m

Develops, manufactures, and markets pharmaceutical products in Palestine, the Middle East, North Africa, and internationally.

Hoth Therapeutics

Market Cap: US$24.0m

A clinical-stage biopharmaceutical company, focuses on developing therapies for unmet medical needs.

SoftOx Solutions

Market Cap: NOK 187.2m

Operates as a clinical-stage pharmaceutical company that develops antimicrobials products for infection prevention and treatment in Norway.

Relief Therapeutics Holding

Market Cap: CHF 40.0m

A biopharmaceutical company, engages in identification, development, and commercialization of novel, patent protected products for the treatment of dermatological, metabolic, and pulmonary rare diseases.

Alkermes

Market Cap: US$4.5b

A biopharmaceutical company, researches, develops, and commercializes pharmaceutical products to address unmet medical needs of patients in therapeutic areas in the United States, Ireland, and internationally.